LSE · Healthcare

Hikma Pharmaceuticals PLC (HIK)

Drug Manufacturers - Specialty & Generic

Hikma Pharmaceuticals PLC (HIK) is listed on LSE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-19, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HIK

P/E ratio

18.00

Hikma Pharmaceuticals PLC (HIK) — FAQ

What is HIK's P/E ratio?

The price-to-earnings (P/E) ratio for Hikma Pharmaceuticals PLC (HIK) is 18.00 (data as of 2026-05-19).

Does Hikma Pharmaceuticals PLC pay a dividend?

Dividend yield is not available in the current snapshot for Hikma Pharmaceuticals PLC (HIK). Check the MyAverix Finance app for the latest dividend data.

What sector is Hikma Pharmaceuticals PLC in?

Hikma Pharmaceuticals PLC (HIK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is HIK listed on?

HIK is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)